0001546927-15-000261.txt : 20151020
0001546927-15-000261.hdr.sgml : 20151020
20151020135022
ACCESSION NUMBER: 0001546927-15-000261
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151015
FILED AS OF DATE: 20151020
DATE AS OF CHANGE: 20151020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protalix BioTherapeutics, Inc.
CENTRAL INDEX KEY: 0001006281
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 650643773
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 SNUNIT ST
STREET 2: SCIENCE PARK, POB 455
CITY: CARMIEL
STATE: L3
ZIP: 20100
BUSINESS PHONE: 972-4-988-9488
MAIL ADDRESS:
STREET 1: 2 SNUNIT ST
STREET 2: SCIENCE PARK, POB 455
CITY: CARMIEL
STATE: L3
ZIP: 20100
FORMER COMPANY:
FORMER CONFORMED NAME: ORTHODONTIX INC
DATE OF NAME CHANGE: 19980422
FORMER COMPANY:
FORMER CONFORMED NAME: EMBASSY ACQUISITION CORP
DATE OF NAME CHANGE: 19960124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Camber Capital Management LLC
CENTRAL INDEX KEY: 0001444043
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33357
FILM NUMBER: 151166044
BUSINESS ADDRESS:
STREET 1: 101 HUNTINGTON AVENUE
STREET 2: SUITE 2550
CITY: BOSTON
STATE: MA
ZIP: 02199
BUSINESS PHONE: 617-717-6600
MAIL ADDRESS:
STREET 1: 101 HUNTINGTON AVENUE
STREET 2: SUITE 2550
CITY: BOSTON
STATE: MA
ZIP: 02199
3
1
camberprotalxform3filed.xml
OWNERSHIP DOCUMENT
X0206
3
2015-10-15
0
0001006281
Protalix BioTherapeutics, Inc.
PLX
0001444043
Camber Capital Management LLC
101 HUNTINGTON AVENUE
SUITE 2550
BOSTON
MA
02199
0
0
1
0
Common Stock
9274577
I
See Footnotes
Convertible Note Contracts
1562933
I
See Footnotes
Securities reported herein for Camber Capital Management LLC (the "LLC" ) represent Common Stock and Convertible Note Contracts (on an as-coverted basis) beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Fund"), another private investment fund (the "Fund") and one managed account (the "Managed Account") for which the LLC serves as the investment manager. Stephen DuBois is the managing member of the LLC and managing member of the general partner for the Fund and the Master Fund. The LLC, the Master Fund, the Fund, the Managed Account, general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 25, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein.
Of the securities reported herein, 8,953,095 shares of Common Stock are held for the account of the Master Fund, 63,057 shares of Common Stock are held for the account of the Fund, and 258,425 shares of Common Stock are held for the account of the Managed Account.
Of the securities reported herein, 8,541 Convertible Note Contracts (equivalent to 1,483,224 shares of Common Stock on an as-coverted basis) are held for the account of the Master Fund, 68 Convertible Note Contracts (equivalent to 11,878 shares of Common Stock on an as-coverted basis) are held for the account of the Fund, and 391 Convertible Note Contracts (equivalent to 67,831 shares of Common Stock on an as-coverted basis) are held for the account of the Managed Account.
Stephen DuBois
2015-10-20